Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
262.00    2.00 (0.77%)
Bid:
252.00
Ask:
262.00
Spread: 10.00 (3.968%)
Market Cap: £234.64m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Director/PDMR Shareholding

9 Jul 2019 16:49

RNS Number : 9963E
Wilmington PLC
09 July 2019
 

9 July 2019

 

Wilmington plc

Director/PDMR Shareholding

 

 

In accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation, Wilmington plc (the 'Company') was advised on 8 July 2019 that:

 

· Richard Amos, Chief Financial Officer, bought 24,250 ordinary shares of 5p each in the Company on 8 July 2019 at an average of 202 pence per share. His resultant holding of ordinary shares of 5p each is 24,250 which represent 0.03% of the issued share capital with voting rights: The shares are registered in the name of his wife Brigid Amos who is the beneficial holder; and

 

· Martin Morgan, Non-Executive Chairman, bought 25,000 ordinary shares of 5p each in the Company on 8 July 2019 at an average of 200 pence per share. His resultant holding of ordinary shares of 5p each is 50,000 which represent 0.06% of the issued share capital with voting rights.

 

 

 

For further information, please contact:

 

Wilmington plc 020 7490 0049

 

Richard Amos, Company Secretary and Chief Financial Officer

 

FTI Consulting 020 3727 1000

 

Charles Palmer / Dwight Burden / Leah Dudley

 

 

Notes to Editors 

Wilmington is the recognised knowledge leader and partner of choice for information, education and networking in Risk & Compliance, Professional and Healthcare areas. Wilmington employs close to 1,000 people and has customers in 120 countries. Wilmington plc is a premium listed Company on the main market of the London Stock Exchange.

 

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR") / person closely associated with them ("PCA")

 

a)

Name

RICHARD AMOS / BRIGID AMOS

 

2.

Reason for the notification

 

a)

Position /status

CHIEF FINANCIAL OFFICER

 

b)

Initial notification / amendment

 

INITIAL NOTIFICATION

3.

Details of the Issuer

 

a)

Name

WILMINGTON PLC

 

b)

LEI code

 

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

Identification code

 

ORDINARY SHARES IN WILMINGTON PLC

 

ISIN: GB0009692319

 

b)

Nature of the transaction

PURCHASE OF ORDINARY SHARES

c)

Price(s) and volume(s)

Price(s)

Volume(s)

2.02

24,250

 

 

 

d)

Aggregated information

Aggregated volume

Price

 

 

N/A

 

 

e)

Date of the transaction

 

8 JULY 2019

f)

Place of the transaction

 

LONDON

 

 

 

Details of the Person Discharging Managerial Responsibility ("PDMR") / person closely associated with them ("PCA")

 

Name

MARTIN MORGAN

 

Reason for the notification

 

Position /status

NON-EXECUTIVE CHAIRMAN

 

Initial notification / amendment

 

INITIAL NOTIFICATION

Details of the Issuer

 

Name

WILMINGTON PLC

 

LEI code

 

N/A

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Description of the financial instrument, type of instrument

Identification code

 

ORDINARY SHARES IN WILMINGTON PLC

 

ISIN: GB0009692319

 

Nature of the transaction

PURCHASE OF ORDINARY SHARES

Price(s) and volume(s)

Price(s)

Volume(s)

2.00

25,000

 

 

 

Aggregated information

Aggregated volume

Price

 

 

N/A

 

 

Date of the transaction

 

8 JULY 2019

Place of the transaction

 

LONDON

   

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHRLMATMBIMBRL
Date   Source Headline
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20254:39 pmRNSDirector/PDMR Shareholding
3rd Mar 20254:35 pmRNSDirector/PDMR Shareholding
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSShare repurchase programme
17th Feb 20257:00 amRNSHalf-year Report
17th Jan 20259:42 amRNSNotice of Half Year Results
4th Dec 20247:00 amRNSDirector/PDMR Shareholding
28th Nov 202411:03 amRNSResult of AGM
25th Nov 20241:37 pmRNSHolding(s) in Company
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
8th Nov 20243:13 pmRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTotal Voting Rights
25th Oct 20247:00 amRNSAcquisition of Phoenix Health & Safety
21st Oct 20241:47 pmRNSDirector/PDMR Shareholding
14th Oct 20247:00 amRNSIssue of Ordinary Shares
1st Oct 20247:00 amRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNSFinancial results for the year ended 30 June 2024
2nd Sep 20247:00 amRNSTotal Voting Rights
29th Jul 20248:59 amRNSDirector Declaration
24th Jul 20247:00 amRNSTrading Statement
10th Jul 202410:57 amRNSHolding(s) in Company
2nd Jul 20242:51 pmRNSTotal Voting Rights - Replacement
1st Jul 20247:00 amRNSTotal Voting Rights
27th Jun 20247:00 amRNSUK Healthcare Business sold for £26.3 million
26th Apr 20247:46 amRNSAPM sold for EUR 26 million
23rd Apr 20243:49 pmRNSSAYE and Director/PDMR Shareholding
19th Feb 20247:00 amRNSHalf-year Report
6th Feb 202411:12 amRNSBoard Changes
1st Feb 20247:00 amRNSMiExact sold for £9.6 million
18th Jan 202411:00 amRNSNotice of Half Year Results
2nd Jan 20247:00 amRNSTotal Voting Rights
18th Dec 20232:42 pmRNSIssue of ordinary shares
11th Dec 20233:54 pmRNSIssue of Ordinary Shares
7th Dec 20232:25 pmRNSIssue of Ordinary Shares
1st Dec 202311:40 amRNSDirector/PDMR Shareholding
30th Nov 20232:53 pmRNSIssue of Ordinary Shares
23rd Nov 20239:49 amRNSAcquisition of Astutis Ltd by Wilmington plc
22nd Nov 20232:37 pmRNSResult of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
3rd Oct 20232:52 pmRNSHolding(s) in Company
2nd Oct 202311:57 amRNSDirector/PDMR Shareholding
2nd Oct 202310:19 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSIssue of Ordinary Shares
25th Sep 20236:06 pmRNSAmendment to Financial Results announcement
25th Sep 20237:00 amRNSFinancial results for the year ended 30 June 2023
26th Jul 20237:00 amRNSTrading Statement
11th Apr 20237:00 amRNSSAYE and Director/PDMR Shareholding
7th Mar 20235:32 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.